Randomised controlled trial of surgical treatment of varicose veins in legs: Stripping versus Conservative Treatment (CHIVA)

ISRCTN ISRCTN52861672
DOI https://doi.org/10.1186/ISRCTN52861672
Secondary identifying numbers FIS 94/5365, FIS 97/0694
Submission date
05/03/2005
Registration date
13/04/2005
Last edited
04/01/2016
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Background and study aims
Varicose veins are swollen and enlarged veins that usually occur on the legs. The condition is highly common and causes a wide range of problems and complications, such as inflammation of the veins, formation of blood clots, and ulcers in some more extreme cases. As a result of several of the conditions mentioned above, patients visit specialists in search of solutions; vascular surgeons generally recommend surgery when necessary. Patients must be made aware that, as the disease is chronic, they can never be healed, and after surgical treatment, varicose veins may appear again some years later (between 20 and 80% of patients over a 5-year period). For over a hundred years, varicose veins have been surgically treated using destructive techniques. Standard practice involves the removal of all diseased veins. Stripping has been the routine procedure applied, in addition to other techniques which were developed later, which include laser, radiofrequency and sclerosis procedures. Hemodynamic Ambulatory Conservative Management of Varicose Veins (CHIVA in French) is a surgical treatment that aims to treat varicose veins without destroying the venous system, and so preserve its functions. Preserving the main vein in the leg, the internal saphenous vein, is also necessary if the patient concerned requires heart or leg arterial surgery. The treatment of reappearing varicose veins after an initial surgical operation using the CHIVA method is much simpler when compared with the treatment with other destructive techniques, which is anatomically more complex. This study was undertaken to find out whether the recurrence of varicose veins is lower after surgery using the CHIVA method compared with stripping.

Who can participate?
Adult patients (18 or older) with primary varicose veins in the legs.

What does the study involve?
Patients are randomly allocated into three groups to be treated with one of three different methods: Stripping Clinic Mapping, Stripping Duplex Mapping or CHIVA. Ultrasounds and clinical follow-up procedures are scheduled for the three groups at 3, 6, 12, 24, 36, 48, 60 and 120 months after surgery.

What are the possible benefits and risks of participating?
As a safety measure, any major complications are evaluated 8 days after the operation.

Where is the study run from?
This study takes place in the Department of Angiology and Vascular Surgery of the University Hospital of Vic, (Barcelona, Spain).

When is the study starting and how long is it expected to run for?
January 1997 to December 2012.

Who is funding the study?
1. Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo (Spanish Ministry of Health) (Spain).
2. Non-Invasive Vascular Diagnosis Area of the Spanish Society for Angiology and Vascular and Endovascular Surgery (Sociedad Española de Angiología y Cirugía Vascular).

Who is the main contact?
Dr Josep Oriol Parés i Rifà

Contact information

Dr Josep Oriol Parés i Rifà
Scientific

C/ Francesc Pla el Vigatà s/n
Hospital Universitari de Vic
Barcelona
08500
Spain

Study information

Study designSingle-center interventional randomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleRandomised controlled trial of surgical treatment of varicose veins in legs: Stripping versus Conservative Treatment (CHIVA)
Study hypothesisMain Hypothesis:
The recurrence number of varicose veins to the saphenous vein system post-intervention by means of the CHIVA method is lower than the one used on Stripping regardless of the marking type system.

Secondary Hypotheses:
1. The recurrence number of varicose veins to the saphenous vein system post-intervention by means of Stripping with an Eco-Doppler mark method is lower than the one used on Stripping with a clinical mark method.
2. CHIVA method patients take fewer sick leave days than those ones treated with either of the others two methods.-
3. The CHIVA method cost is lower than the Stripping one regardless of the marking type system.
Ethics approval(s)Ethics Committee for Clinical Research of the University Hospital of Vic, 21/07/2011, FIS 94/5365, FIS 97/0694
ConditionVaricose veins in legs
InterventionStripping with clinic marking, Stripping with Eco-Doppler marking, Conservative Treatment (CHIVA)
Intervention typeProcedure/Surgery
Primary outcome measureThe clinic and haemodynamic determination of the recurrences number and the time between the intervention and recurrence will be calculated.
Secondary outcome measures1. Time until medical discharge
2. Clinical and haemodynamic improvement
3. Satisfaction rate
4. Cost for each group
Overall study start date01/01/1997
Overall study end date31/12/2012

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants501
Participant inclusion criteriaPatients affected by varicose veins of the lower extremities.

Added 23/11/2015:
The study included patients diagnosed with primary varicose veins in an external consultation by a vascular surgeon, according to the CEAP (CA-S, 2–6; EP; AS, P; PR; LII) classification criteria and with permeable, continent deep venous system upon duplex ultrasonography exploration. In patients with varicose veins in both extremities, only 1 limb could be randomized.
Participant exclusion criteriaPatients previously operated for varicose veins with recurrent varicose veins will be excluded.

Added 23/11/2015:
All patients with congenital venous disease, varicose veins secondary to prior deep vein thrombosis, postphlebitic side-effects, sclerotherapy, relapse of varicose veins after surgery, associated systemic pathologies, or who refused to participate in the study, refused surgical treatment, were not ambulatory, could not participate in long-term follow-up or had been pregnant less than 6 months previously were excluded from the study.
Recruitment start date01/02/1998
Recruitment end date01/04/2001

Locations

Countries of recruitment

  • Spain

Study participating centre

Hospital Universitari de Vic
C/ Francesc Pla el Vigata
Barcelona
08500
Spain

Sponsor information

Spanish Ministry of Health, Investigation of Sanitary Funding (Fondo de Investigación Sanitaria Ministerio de Sanidad y Consumo)
Government

C/Sinesio Delgado, nº 6
Madrid
28029
Spain

Website http://www.isciii.es/htdocs/index.jsp
ROR logo "ROR" https://ror.org/00f3x4340

Funders

Funder type

Government

Investigation Sanitary Funding of Spanish Ministry of Health (Fondo de Investigación Sanitaria, Ministerio de Sanidad y Consumo) (Spain) (refs: 94/5365 and 97/0694)

No information available

Non-Invasive Vascular Diagnosis Chapter of Spanish Society of Angiology and Vascular Surgery (Capítulo de Diagnóstico Vascular no Invasivo de la Sociedad Española de Angiología y Cirugía Vascular) (Spain)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryStored in repository
Publication and dissemination planThe study has been published in http://www.ncbi.nlm.nih.gov/pubmed/20224376. We are currently preparing the publication of the results at 10 years of follow up in 2016.
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/04/2010 Yes No

Editorial Notes

On 23/11/2015 the overall trial end date was changed from 31/12/2007 to 31/12/2012.